CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- 4 Planned sale Director sold 7,229 shares at $39.66 ($286,715)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 1,211 shares (option exercise)
- 4 Planned sale GENERAL COUNSEL & CORP SEC sold 3,978 shares at an average $32.28 ($128,411)
- 4 Planned sale Director sold 13,430 shares at an average $32.27 ($433,385)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,358 shares at an average $31.19 ($167,115)
- 4 Planned sale Director sold 15,001 shares at an average $31.13 ($466,959)
- 4 Planned sale GENERAL COUNSEL & CORP SEC sold 9,803 shares at an average $31.25 ($306,322)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 4,020 shares at an average $30.22 ($121,468)
- 4 Open-market sale Director sold 2,136 shares at an average $30.22 ($64,541)
- 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 4,576 shares at an average $30.22 ($138,268)
- 4 Planned sale Director sold 40,472 shares at $29.72 ($1,202,719)
- 4 Planned sale Director sold 40,472 shares at an average $26.98 ($1,092,058)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,931 shares at an average $25.72 ($152,566)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 25,000 shares at $30.00 ($750,000)
Page 3 of 16 · 305 filings